Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome | MicrobiomeTrials← Back to trialsNCT07743242
Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06-05Est. Completion: 2027-11-30
Enrollment target: 230 participants Locations- New Valley University, Al Khārjah, Kharga Oasis, Egypt
Other microbiome trials you might be interested in
Systemic Lupus ErythematosusSystemic SclerosisInflammatory MyopathyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid SyndromeSjogren's Syndrome
An exploratory clinical study of the safety and efficacy of YTS109 cell injection in subjects with recurrent/refractory …
Shanghai, ChinaEst. completion Apr 21, 2027
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Antiphospholipid Syndrome (APS)
Rheumatoid Arthritis (RA)
IgG4-Related Diseases
Sjogren's Syndrome
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, suc…
Beijing, ChinaEst. completion May 19, 2027
Autoimmune Disorders
The purpose of this study is to see if the study medication, daratumumab, is safe to treat individuals with Anti-Phospho…
Baltimore, United StatesEst. completion May 5, 2028